1. Macfarlane, JT, et al. Prospective study of aetiology and outcome of adult0 lower respiratory tract infections in the community. Lancet 1993; 341: 511–514.
2. Dixon, RE. Economic costs of respiratory tract infections in the United States. American Journal of Medicine 1985; 78: 45–51.
3. Niederman, MS, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. American Journal of Respiratory and Critical Care Medicine 2001; 163: 1730–1754.
4. Woodhead, M, et al. Guidelines for the management of adult lower respiratory tract infections. European Respiratory Journal 2005; 26: 1138–1180.
5. Fine, MJ, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. New England Journal of Medicine 1997; 336: 243–250.
6. Lim, WS, et al. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax 2001; 56: 296–301.
7. Lim, WS, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58: 377–382.
8. Neill, AM, et al. Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax 1996; 51: 1010–1016.
9. Justice, AC, Covinsky, KE, Berlin, JA. Assessing the generalizability of prognostic information. Annals of Internal Medicine 1999; 130: 515–524.
10. Flanders, WD, et al. Validation of the pneumonia severity index. Importance of study-specific recalibration. Journal of General Internal Medicine 1999; 14: 333–340.
11. Yan Man, S, et al. Prospective comparison of three predictive rules for assessing severity of community-acquired pneumonia in Hong Kong. Thorax 2007; 62: 348–353.
12. Capelastegui, A, et al. Validation of a predictive rule for the management of community-acquired pneumonia. European Respiratory Journal 2006; 27: 151–157.
13. Marras, TK, Gutierrez, C, Chan, CK. Applying a prediction rule to identify low-risk patients with community-acquired pneumonia. Chest 2000; 118: 1339–1343.
14. Buising, KL, et al. A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia. Thorax 2006; 61: 419–424.
15. Ewig, S, et al. Validation of predictive rules and indices of severity for community acquired pneumonia. Thorax 2004; 59: 421–427.
16. Spindler, C, Ortqvist, A. Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia. European Respiratory Journal 2006; 28: 816–823.
17. Aujesky, D, et al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. American Journal of Medicine 2005; 118: 384–392.
18. Christ-Crain, M, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004; 363: 600–607.
19. Christ-Crain, M, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. American Journal of Respiratory and Critical Care Medicine 2006; 174: 84–93.
20. Steyerberg, EW, et al. Validation and updating of predictive logistic regression models: a study on sample size and shrinkage. Statistics in Medicine 2004; 23: 2567–2586.
21. Steyerberg, EW, et al. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. Journal of Clinical Epidemiology 2001; 54: 774–781.
22. Poses, RM, Cebul, RD, Centor, RM. Evaluating physicians' probabilistic judgments. Medical Decision Making 1988; 8: 233–240.
23. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 2006.
24. Harrell, FE. Design: Design Package. R package version 2.0-12, 2005.
25. van Houwelingen, HC. Validation, calibration, revision and combination of prognostic survival models. Statistics in Medicine 2000; 19: 3401–3415.
26. Vergouwe, Y, et al. Substantial effective sample sizes were required for external validation studies of predictive logistic regression models. Journal of Clinical Epidemiology 2005; 58: 475–483.